Carcinoma, Non Small Cell Lung

A Clinical Trial of PF-08046037 Alone or With Sasanlimab in Patients With Advanced or Metastatic Malignancies

A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Study of Pemetrexed Plus Cisplatin as First-line Therapy in Patients With Advanced Non-squamous NSCLC

Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.

Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer

Docetaxel +/- Suramin in 2nd Line Advanced Non-Small Cell Lung Cancer

Vorinostat and Bortezomib as Third-line Treatment in Advanced Non-small Cell Lung Cancer

Intra-patient Dose Escalation Study of Sorafenib in Advanced Non-small Cell Lung Cancer

A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)

PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib

A Study Of PF-06263507 In Patients With Advanced Solid Tumors

Healthy Directions After Lung Surgery Pilot

Computed Tomography (CT) Perfusion Imaging of Lung Cancer

Trial of ZD6474 and Faslodex in Non-Small Cell Lung Cancer

TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer

Tarceva and AT-101 for Patients With Advanced Non-Small Cell Lung Cancer

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Non-small-cell Lung Cancer

Validation of Coregistered CT-PET Imaging in Determining Tumor Volume and Atelectasis in Patients With Operable Non-Small-Cell Lung Cancer and Tumor Associated Atelectasis

Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer

Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer